InsiderClue
Insiders · Profile

Sohn Catherine A.

Director at Maze Therapeutics · Director at Altimmune · Director at Jazz Pharmaceuticals · and 1 more. Filing since 14 Aug 2013. CIK 0001555132

MAZE Maze Therapeutics, Inc. Director · 2 trades ALT Altimmune, Inc. Director · 2 trades JAZZ Jazz Pharmaceuticals plc Director · 13 trades LFCR LIFECORE BIOMEDICAL, INC. DE Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
MAZE Maze Therapeutics, Inc.
7 Jan 2026
Director
Sold at will
26,920
$1.05M
100%
MAZE Maze Therapeutics, Inc.
6 Jan 2026
Director
Sold at will
2,493
$96.27K
100%
ALT Altimmune, Inc.
5 Jan 2026
Director
Bought
500
$2.12K
50.0%
ALT Altimmune, Inc.
17 Mar 2025
Director
Bought
1,000
$5.78K
opened
JAZZ Jazz Pharmaceuticals plc
14 Aug 2023
Director
Sold at will
1,241
$171.45K
7.7%
JAZZ Jazz Pharmaceuticals plc
8 Aug 2022
Director
Sold, plan not stated
1,089
$165.88K
7.7%
JAZZ Jazz Pharmaceuticals plc
6 Aug 2021
Director
Sold, plan not stated
1,306
$193.24K
10.1%
JAZZ Jazz Pharmaceuticals plc
4 Nov 2020
Director
Sold, plan not stated
12,500
$1.92M
54.1%
JAZZ Jazz Pharmaceuticals plc
7 Aug 2020
Director
Sold, plan not stated
931
$117.19K
8.1%
JAZZ Jazz Pharmaceuticals plc
9 Aug 2019
Director
Sold, plan not stated
726
$98.48K
7.6%
LFCR LIFECORE BIOMEDICAL, INC. DE
10 Jan 2019
Director
Bought
1,000
$11.23K
4.2%
JAZZ Jazz Pharmaceuticals plc
10 Aug 2018
Director
Sold, plan not stated
660
$116.56K
7.9%
JAZZ Jazz Pharmaceuticals plc
11 Aug 2017
Director
Sold, plan not stated
662
$94.25K
8.8%
JAZZ Jazz Pharmaceuticals plc
15 Aug 2016
Director
Sold, plan not stated
633
$86.37K
9.4%
JAZZ Jazz Pharmaceuticals plc
11 Aug 2015
Director
Sold, plan not stated
654
$116.29K
10.8%
JAZZ Jazz Pharmaceuticals plc
10 Aug 2015
Director
Sold, plan not stated
801
$144.18K
11.7%
JAZZ Jazz Pharmaceuticals plc
12 Aug 2014
Director
Sold, plan not stated
1,731
$230.48K
23.8%
JAZZ Jazz Pharmaceuticals plc
14 Aug 2013
Director
Sold, plan not stated
640
$51.85K
10.2%
18 decisions on file.